skip to the main content

Anti-CCP Plus

Supporting to distinguish and diagnose rheumatoid arthritis

This test helps to diagnose and provide appropriate treatment for chronic systemic autoimmune diseases and rheumatism by quantifying Anti-CCP in the blood.

Diagnosis diseases
Rheumatoid Arthritis
  • CE 0123
  • ANVISA

About Using Reagent

  • Sample Types

    whole blood, plasma, serum
  • Reaction Time

    12 mins
  • Detection Range

    AFIAS (3.2 – 300 U/ml)
    ichroma™ (3.5 – 300 U/ml)
  • Indication

    Rheumatoid arthritis, autoimmune disease

Available Accessory

In Your Medical Field

It supports to diagnose rheumatoid arthritis at an earlier stage by quantifying anti-citrulline peptide antibody (Anti-CCP) in the blood to minimize complications and tissue damage by distinguishing it from other types of arthritis and other inflammatory diseases. Furthermore, it is useful for monitoring the effectiveness of treatment and treatment as appropriate.

Our Efforts to be with you